Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.

BMC genomics - 1 Jan 2015

LaConti Joseph J, Laiakis Evagelia C, Mays Anne Deslattes, Peran Ivana, Kim Sung Eun, Shay Jerry W, Riegel Anna T, Fornace Albert J, Wellstein Anton

Abstract excerpt

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer deaths worldwide with less than a 6% 5-year survival rate. PDAC is associated with poor prognosis based on the late stage diagnosis of the disease. Current diagnostic tests lack the sensitivity and specifici...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Pancreatic Ductal
Share to Citrate (si)-Synthase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Citric Acid

Share to Mass Spectrometry

Share to Metabolomics

Share to Multivariate Analysis

Share to Pancreatic Neoplasms

Share to Proto-Oncogene Proteins p21(ras)

Source

Open in PubMed Open full text

Identifiers

PMID: 25923219
DOI: 10.1186/1471-2164-16-S1-S1
PMCID: PMC4315147

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25923219-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.PMID 25923219Read ↗

Mass profiling of serum to distinguish mice with pancreatic cancer induced by a transgenic Kras mutation.Semantic proximity Read ↗

Screening Metabolic Biomarkers in KRAS Mutated Mouse Acinar and Human Pancreatic Cancer Cells via Single-Cell Mass Spectrometry.Semantic proximity Read ↗

Metabolic and Lipoprotein Profiling of Pancreatic Ductal Adenocarcinoma Patients of African AncestrySemantic proximity Read ↗

Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance.Semantic proximity Read ↗

Tumour genotype shapes blood biomarker expression for use in pancreatic cancer detection and diagnosisSemantic proximity Read ↗

Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic CancerSemantic proximity Read ↗

Integrating metabolic profiling of pancreatic juice with transcriptomic analysis of pancreatic cancer tissue identifies distinct clinical subgroupsSemantic proximity Read ↗

A Mouse to Human Search for Plasma Proteome Changes Associated with Pancreatic Tumor DevelopmentSemantic proximity Read ↗

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.Semantic proximity Read ↗

Evolutionary metabolic landscape from preneoplasia to invasive lung adenocarcinomaSemantic proximity Read ↗

Exploring the metabolic landscape of pancreatic ductal adenocarcinoma cells using genome-scale metabolic modelingSemantic proximity Read ↗

Exploring the metabolic landscape of pancreatic ductal adenocarcinoma cells using genome-scale metabolic modelingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.